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Abstract 
DMT1, also known as Nramp2, is an iron transporter, and belongs to the family of Nramp proteins. 
Disease-causing mutations both in Nramp1 and Nramp2 occurring at the conserved two adjacent 
glycine residues located within the fourth transmembrane domain (TM4) suggest that TM4 may serve 
an important biological function. In the present study, we have determined the high-resolution 
structures of a synthetic peptide, corresponding to the sequence of the fourth transmembrane domain 
of rat DMT1 with G185D mutation, in membrane-mimetic environments (e.g. SDS micelles) using 
NMR spectroscopy and distance-geometry/simulated annealing calculations. The spatial structures 
showed α-helices without kink in the middle portion of the peptide, with highly flexible and poorly 
defined N-terminus. Both the N-terminus and helical core of the peptide were embedded into the SDS 
micelles. Interestingly, the folding and membrane location of the C-terminus was pH-dependent, being 
well-folded and inserted into SDS micelles only at a low pH value (4.0). The peptide exhibited 
amphipathic characteristics, with hydrophilic residues (Asp7, Thr11, Asp14 and Thr15) lying in one 
side of the helix which provide a basis for the formation of water-filled channel architectures through 
self-associations. The significant broadening of the resonances of the hydrophilic residues Asp7, 
Thr11, Asp14 which are buried inside SDS micelles, upon addition of Mn2+ further verified the 
possibility of the formation of a channel through which metal ions pass. The substitution of Gly7 by an 
aspartate residue neither significantly altered the structure and membrane location of the peptide nor 
abolished its properties of channel-forming and metal permeation compared with the wild-type 
peptide. 
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   INTRODUCTION 
The divalent metal transporter (DMT1), also known as Nramp2, is the first mammalian transmembrane 
iron transporter that actively transports reduced dietary iron into intestinal enterocytes and also 
transports iron across the membrane of acidified endosomes in pheripheral tissues.1-4 It is an integral 
membrane protein formed by 12 putative transmembrane domains, several of which contain charged 
residues. It belongs to the family of Nramp proteins highly conserved from bacteria to human beings,1,2 
and shares 78% sequence identity in the hydrophobic core with Nramp1, a protein involved in defense 
against intracellular pathogens.2 Functional studies in Xenopus lavis oocytes and cultured mammalian 
cells have shown that DMT1 is an electrogenic transporter of divalent metal ions (including Fe2+, Zn2+ 
and Mn2+), and the transport appears to be dependent on pH and coupled to proton symport. 1,5-7 
    Genetic studies in rodent models of iron deficiency and microcytic anemia have shown that the 
DMT1 gene is mutated (G185R) in the mk mouse and in the Belgrade rat.2,8 Both animals exhibit 
severe iron deficiency anemia due to defects in intestinal iron transport and erythroid iron utilization. 
Transient expression studies in HEK293T cells have shown that DMT1 carrying the G185R mutant is 
severely function-impaired and cannot significantly stimulate iron uptake.5 Strikingly, naturally 
occurring mutation (G169D) in Nramp1 abrogates natural resistance to infection with intracellular 
parasites.9 Both disease-causing mutations occurred at the two adjacent glycine residues, conserved 
within the predicted transmembrane domain 4 of the proteins. This remarkably narrow spectrum of 
disease-causing mutation in Nramp proteins suggests that TM4 may serve a unique and important 
biological function. 
    There are serious obstacles in applying the most widely used methods for mimicking membrane 
protein structural studies. In particular, they are notoriously difficult to crystallize and 
multidimensional NMR methods are also hampered by the slow reorientation rate of proteins 
complexed with lipids. 10  Detergent micelles have been established as well-accepted models for 
membrane environments.11 Fortunately, multidimensional solution NMR methods are feasible for the 
study of the structures of peptides and proteins in micelles, although the line-widths are five times 
broader than those in aqueous solution. Model peptides, corresponding to the sequence of functional 
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domains or segments, have been demonstrated to be ideal objects for investigation of structure and 
function in several integral membrane proteins.12-18 
    There appears no prior knowledge on structure and assembly of integral DMT1. We have 
previously characterized the structures and membrane orientations and self-assembly of TM4 peptides 
for both the wild-type and the G185R mutant in membrane-mimetic SDS micelles.19,20 In the current 
study, the secondary structure of TM4 peptide with G185D mutation (G185D peptide) has been 
characterized in SDS micelles by CD and NMR spectroscopic techniques. The three-dimensional 
structures of the peptide bound to SDS at different pH values have been computed by molecular 
dynamics with simulated annealing calculations using the CYANA software package. 21  Several 
homonuclear two-dimensional NMR techniques such as TOCSY 22 , 23  and NOESY 24 , 25  have been 
utilized to derive the complete proton resonance assignments. The interproton distances in three-
dimensional space were determined from the NOESY cross-peak intensities. The orientation of the 
peptide relative to SDS micellar surface was probed by the effects of paramagnetic agents, such as the 
16-doxyl-stearic acid spin label and Mn2+, on the broadening of NMR resonances of the peptide. The 
peptide was embedded into the micelles with the C-termini exposed outside the micelles at pH 5.5. A 
possible assembly to form a water-filled channel through self-association was discussed.   
 
METHODS 
Sample Preparation 
The sequence of the G185D peptide was taken from the 4th transmembrane domain of rat DMT1 with a 
single point mutant, which was underlined (179RVPLYGDVLITIADTFVFLFLDKY202). The G185D 
peptide was prepared by solid-phase synthesis and purified by HPLC on a Zorbax SB Phenyl reverse 
phase column using 0.1% TFA/water and 0.1% TFA/acetonitrile as solvents (Biopeptide CO. LLC. 
USA). Purity was evaluated by both HPLC and mass spectrometry to be above 95%. All D2O, SDS-d25 
and methonal-d4 were purchased from Cambridge Isotopes Laboratories (MA). 1,1,1,3,3,3,-hexafluoro-
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2-propanol (HFIP), and 16-doxyl-stearic acid spin label were obtained from Sigma in the highest 
available purity and were used without further treatment. 
    The sample containing the G185D peptide in micellar solution was prepared using a previously- 
described method.19 About 3.2 mg of the peptide, dissolved in HFIP (or in 0.6 ml TFE-d2 for diffusion 
experiments), mixed with an equal volume of SDS-d25 aqueous solution, and the mixture was further 
diluted with water to give rise to a 16: 1 ratio of water to HFIP and was subjected to lyophilization 
overnight. The resulting powder was dissolved in 0.6 ml water (containing 10% D2O), which gave rise 
to ca. 2 mM peptide and 300 mM SDS-d25. The pH values of the sample were adjusted by addition of 
NaOH or HCl. The 16-doxyl-stearic acid was added as a solution in a least amount of methanol-d4 to 
give a molar ratio of detergent to spin-label of 60: 1.  To measure the rate of deuterium exchange with 
amide protons, the peptide sample was lyophilized and dissolved in D2O, pH* 5.3 (direct pH-meter 
readings). 
 
CD Spectroscopy 
CD experiments were carried out on a Jasco-720 spectropolarimeter. All measurements were made at 
room temperature in a quartz cuvette of 1-mm path length. Spectra were recorded over the far-UV 
range of 190-260 nm with a time constant of 0.25 s, a spectral resolution of 0.1 nm, and a scan rate of 
50 nm/min. Three scans were averaged for each spectrum, and the reference spectra of the respective 
media were subtracted. The peptide concentration for CD studies was 20 µM and SDS of 50 mM. The 
helicity was estimated by both deconvolution of CD spectra using CDPro software 26 and calculation 
using an empirical method described previously, on the assumption that the [θ]222 for 0% and 100% α-
helix contents were 2000 and 30000 deg cm2 dmol-1, respectively.27,28 
 
NMR Spectroscopy 
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The NMR experiments were performed at 298 K on a Bruker AV600 spectrometer. Two-dimensional 
NMR experiments were carried out in a phase sensitive mode using the States-TPPI 29 for quadrature 
detection in the F1 dimension. Typically, 48-80 scans were collected with 2 K data points in F2 and 
512 increments in F1 dimension. TOCSY experiments were performed with the MLEV-17 pulse 30 
with a spin-lock time of 100 ms. NOESY spectra 24,25 were acquired with mixing times of 50, 150, 200 
and 250 ms. Water signals were suppressed using WATERGATE.31,32 Chemical shifts were referenced 
by sodium salt of trimethylsilylpropionate (TSP-d4).    
    The fast and slow exchanging amide protons were detected by a series of one-dimensional 1H and 
two dimensional NOESY experiments (mixing time 200 ms), recorded shortly after a lyophilized 
sample was dissolved in D2O at pH* 5.3 (direct meter reading). The effect of 16-doxyl-stearic acid on 
the NMR signals was monitored by recording NOESY spectra in the absence and presence of the spin 
label. Paramagnetic metal ion broadening studies were performed in the presence of Mn2+ at 
concentrations of 0.1, 0.2 and 1.0 mM at pH 5.5 and 4.0. Similarly, the NOESY spectra (mixing time 
200 ms) were recorded before and after addition of MnCl2. The amplitudes of the spectra in the 
presence of 16-doxyl-stearic acid and paramagnetic metal ions were normalized to the least affected 
cross-peaks. 
All NMR spectra were processed using standard Brüker software (XWINNMR Version 3.1). Prior 
to Fourier transform data were zero-filled to 2K data points in F1 dimension and then transformed with 
a shifted sine-bell squared window function in both dimensions.  
Diffusion coefficient measurements (diffusion ordered spectroscopy (DOSY) experiments) were 
performed on a Bruker DRX 500MHz spectrometer equipped with a z-axis gradient coil. The DOSY 
spectrum was acquired in a 5 mm sample tube at 25°C. The gradient strength was calibrated using 
HDO signal in D2O.33 The stimulated echo bipolar pulse sequence using WATERGATE for water 
suppression was applied to the DOSY experiment. The diffusion time (∆) of 250 ms was used in all 
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experiments. The duration of the gradient pulse (δ) were 2.3 the peptide in order to obtain a 1-5% 
residual signal with the maximum gradient strength. After Fourier transformation and baseline 
correction, the diffusion dimension was processed with the two-exponential decays using the 
XWINNMR software. The apparent molecular mass (M) was calculated based on diffusion coefficient 
(D) assuming the peptides to be a prolate ellipsoid in TFE: 34  
)]](3/[4[)6/( 112
3 νδνππη += AB NFDTkM                  (1) 
where kB is the Boltzmann constant, T is the absolute temperature, η is the viscosity of the 
solution (1.35x10-3 N s m-2 for the peptide/TFE solution35), NA is Avogadro’s number, ν1 and ν2 are the 
specific volumes of the solvent molecule (TFE) and the peptide, respectively36, and δ is the fractional 
amount of TFE bound to the peptide and a value of 0.4 was used under the condition used.  The shape 
factor (F) of 1.0325 was used for a prolate ellipsoid with an axial ratio of 0.55 for the peptide in TFE.34  
 
Distance Restraints and Spatial Structure Calculation 
The spatial structure calculation was performed with the program CYANA (version 1.0),21 which 
employs a simulated annealing algorithm in the torsion angle space. Distance restraints of the peptide 
were obtained from the 2D NOESY spectrum with a mixing time of 200 ms. The NOESY spectrum 
was analyzed using the Sparky software,37 through which both NOE intensities and chemical shifts 
were extracted and served as an input for the program of CYANA.21 The final input included the 
meaningful upper-limit restraints and dihedral angle restraints derived from the GRIDSEARCH. In no 
case could the stereo-specific assignment be achieved. The 200 randomized starting structures were 
energy minimized and the 30 CYANA conformers with the lowest target function values were further 
refined with the AMBER7 program,38,39 using the AMBER94 all-atom force-field.40 
    From the calculated structures, 20 best-converged energy-minimized structures were selected to 
represent the NMR structures. The quality of the final structures was assessed using the PROCHECK-
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NMR program.41 Visual analysis of the structures and figure drawings were performed using the 
MOLMOL program.42 
 
RESULTS  
Secondary Structure Estimation by CD Spectroscopy 
CD spectroscopy is a well-established technique for investigating the secondary structure of proteins 
and peptides. It is particularly useful for monitoring the structural transient of membrane peptides from 
aqueous media upon insertion into membrane environments. 43 , 44  The G185D peptide is highly 
hydrophobic and insoluble in water and many commonly used organic solvents. We therefore 
incorporated the peptide into SDS micelles to solublize the peptide and to mimic biological 
environments.  The CD spectra of 20 µM G185D peptide solublized in 50 mM SDS micelles at 
different pH values are shown in Figure 1. The spectra were characterized by double minima at 208 
and 222 nm and a positive maximum at 194 nm, indicative of a predominant α-helical conformation. 
The CD spectra of the G185D peptide in TFE and DPC micelles were very similar to those in SDS 
micelles (data not shown). The spectra were deconvoluted using CDPro software,26 which has been 
verified as a reliable approach for analysis of secondary structures of membrane peptides in detergent 
micelles or phospholipids.19,45 The α-helical contents were estimated to be ca. 50% and 41% at pH 4.0 
and 7.4, respectively, similar to both wild-type DMT1-TM4 and G185R peptide under similar 
conditions.19,20 The calculation based on empirical method produced similar results.27,28 The 
conformation of the peptide was dependent on pH values with a higher helical content observed at a 
lower pH value. 
 
NMR Assignments and Secondary Chemical Shifts 
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The 2D NMR spectra were well resolved at a wide range of pH values (4.0 to 7.4). All NMR spectra 
were assigned according to classical procedures, including spin system identification and sequential 
assignment.46 Initial spin system assignments were obtained using TOCSY spectra and a NOESY 
spectrum was then used to identify sequential backbone connectivities. The aromatic spin systems of 
Tyr5, Phe16, Phe18, Phe20 and Tyr24 were verified by the NOE connectivities between aliphatic and 
aromatic protons. Most of the side chains have been assigned except for a few aromatic side chains 
(e.g. Phe16, Phe18 and Phe20), where complete assignment was not possible due to spectral overlap. 
The assignments were made for the G185D peptide in SDS micelles at various pH values (4.0, 5.5 and 
7.5). Figure 2 represents the fingerprint region of the NOESY spectrum of the G185D peptide in SDS 
micelles at pH 5.5. The chemical shifts for the backbone protons of the G185D peptide were compared 
with those for the wild-type (DMT1-TM4) at pH 4.0 and 7.4, as shown in Figure S1. Mutation of Gly7 
to Asp7 only caused significant changes in chemical shifts for its nearby residues, such as Tyr5, Gly6, 
Val8, Leu9, Ile10, Thr11, Ile12 and Ala13, but produced little changes in chemical shifts for both the 
N- and C-terminal residues. 
   The chemical shifts of the Hα protons provide information about secondary structure elements as 
reported by Wishart and coworkers.47 The larger the deviation of the Hα proton chemical shift relative 
to random coil values,48 the more pronounced the secondary structure element should be. A local α-
helical structure is indicated by upfield shifts relative to random coil values.47 The chemical shift 
deviations relative to random coil values for the Hα of the G185D peptide in SDS micelles at different 
pH values were calculated, and are shown in Figure 3. In general, chemical shifts were close to random 
coil values at higher pH values except for Leu19 and Tyr24, suggesting that the peptide becomes less 
structured at such pH values. The changes of pH values induced dramatic changes in Hα chemical 
shifts for the C-terminal residues, in particular for Phe20 and Leu21, indicating that the folding of the 
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C-terminus is highly pH dependent. As illustrated in Figure 3, the peptide adopts predominantly α-
helical conformations, consistent with NOE patterns (vide infra). 
    Several medium range NOEs, i.e. dαN(i,i+3), dαβ(i,i+3) and dαN(i,i+4), and strong sequential NOEs 
between amide protons also supported a helical structured peptide in the middle portion (Figure 4). 
More medium-range NOEs were found at the C-terminus at pH 4.0, indicative of a more helical 
structure at a lower pH value and consistent with our CD experiments. There was a lack of medium 
range NOEs in the N-terminus at all pH values studied, which implies that the N-terminus is in an 
extended conformation. 
 
Spatial Structures of G185D Peptide in SDS Micelles  
The three-dimensional structures of the G185D peptide in SDS micelles were obtained based on a total 
of 287 (pH 4.0), 345 (pH 5.5) and 345 (pH 7.4) NOE assignments, 197, 246 and 240 non-redundant 
distance restraints (Table I). A set of 200 structures of the peptide in SDS micelles at each pH value 
was calculated. The 30 structures with the lowest target function values were selected with no distance 
violations greater than 0.2 Å, and no angle constraint violations greater than 5o. The final 20 best-
converged energy-minimized conformers were selected at each pH value to represent its structures in 
micelles. Statistics from PROCHECK-NMR41 show that in the well-defined region in each pH value, 
over 90% of the backbone dihedral angles occupied the most favored regions of the Ramachandran 
space, and none were found in the disallowed region (Table I).  The pair-wise root mean square 
deviations (RMSDs) between the 20 best-converged energy-minimized structures and mean structures 
were also analyzed at different regions (Table I). The results showed that the structures were well-
defined at each helical segment at different pH values.  
    Figure 5A shows superimpositions of the backbone atoms (Leu9-Phe18) of the final 20 best-
converged energy-minimized structures in SDS micelles at pH 4.0, 5.5 and 7.4. The overall structures 
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were characterized by a well-defined helical region flanked by disordered N and C-termini.  The N-
terminus from Arg1 to Gly6 was flexible and disordered at all pH values studied, while the C-terminus 
became well-folded only at low pH values, as evidenced by the presence of dαN(i,i+3) and dαN(i,i+4) 
interactions between residues 20-24 at a such pH (4.0). The length of helix was dependent on pH 
values (e.g. Leu9 to Asp22 at pH 4.0 versus Val8 to Phe18 at pH 7.4). The C-terminus was bent 
towards the helical axis at higher pH values. The peptide exhibited a similar structure at pH 5.5 to that 
at pH 7.4. The side chains of the peptide at pH 5.5 are shown in Figure 5B. It can be seen clearly that 
the peptide has an amphipathic characteristic with the hydrophilic residues Asp7, Thr11, Asp14 and 
Thr15 lying in one side of the helix, while the opposite side of the helix is occupied by hydrophobic 
residues. The residue Pro3 adopted a trans conformation, evidenced by the presence of strong NOE 
between the Hα of Val2 and Hδ of Pro3. The results from the tertiary structure calculation agree 
relatively well with the suggestions based on NOE patterns and secondary chemical shift analysis. The 
H-bonds of  →COi, which are characteristic for α-helices, were found in the well-defined regions 
for the majority conformers of the G185D peptide at various pH values, indicating that the H-bonding 
plays an important role in stabilizing the structure of the peptide. 
N
4H +i
    Electrostatic potential maps for the contact surface of the calculated structures for the G185D 
peptide in SDS at both pH 4.0 and 7.4 were computed using the MOLMOL program. The charge 
distribution showed amphipathic characteristics. Negative charged Asp7, Asp14 and Asp22 lay in one 
side of the helix, while the opposite side of the helical-core region was quite hydrophobic, although 
with positive charged Arg1 and Lys23 flanking at both ends (Figure 6). The negatively charged surface 
of the peptide was not parallel to the helical axis at pH 7.4, but twisted along the helix and bent at the 
C-terminus, consistent with calculated structures. These amphipathic properties might provide a basis 
for the peptide self-assembly to form channel architectures.   
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Amide Proton Exchange Experiments  
One-dimensional 1H NMR spectra were recorded at different time intervals after the addition of D2O in 
the lyophilized peptide sample containing 300 mM SDS-d25 at pH* 5.3. The 2D NOESY spectra were 
then recorded after no obvious changes occurred in the 1D spectrum (ca. 150 min). It was noticed that 
the amide protons of both the N- and C-terminal residues exchanged rapidly and disappeared after ca. 
60 min, while those residues involved in the formation of helix exchanged slowly (data not shown). 
However, Asp14 exchanged relatively quickly and disappeared within 2 hrs after the addition of D2O. 
After 22.5 hrs, only Ile10, Ile12, Ala13, Phe16, Val17 and Phe20 were still observable in the NOESY 
spectrum (data not shown). All the amide protons disappeared from 1D spectrum after 48 hrs. This 
experiment demonstrated that the H-bonding played an important role in the stabilization of the 
peptide. Rapid exchange of amide protons of polar residues indicated there is a solvent accessibility in 
the structure. 
 
Membrane Location  
Effect of 16-Doxyl-Stearic Acid Spin Label on the 1H NMR Signals  
Paramagnetic spin label was used to probe the positioning of the peptide relative to the surface and 
interior of the micelle. The relaxation agent, 16-doxyl-stearic acid, contains doxyl headgroups, a cyclic 
nitroxide with unpaired electrons attached to the aliphatic chain carbon in the position of 16. Previous 
studies have demonstrated that the doxyl group of the relaxation agent 16-doxyl-stearic acid is located 
close to the center of the micelle.49 
    Specific broadening or even missing of the proton signals in the G185D peptide in SDS micelles 
was monitored by using NOESY (or TOCSY) spectra at a SDS/spin label molar ratio of 60:1, i.e. 
approximately one spin label per micelle. The addition of 16-doxyl-stearic acid into the peptide/SDS 
micelle solution at pH 5.5 resulted in a significant broadening of the Hα-HN cross-peaks of Ala13, and 
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a moderate broadening of the cross-peaks of residues situated in both the helical core region and the N-
terminal region (Figure 7). This indicated that residues of both the N-termini and helical core are 
embedded in the micelles. However, no broadening was found for the C-terminal residues (Phe20-
Tyr24) in the presence of 16-doxyl-stearic acid (Figure 7), suggesting that the C-terminal residues may 
be exposed outside the SDS micelles in the aqueous phase. Similar changes occurred at pH 4.0 upon 
addition of 16-doxyl-stearic acid (data not shown), implying no significant alternation in the location 
of the peptide relative to SDS micelle surface.  
 
Effect of Paramagnetic Metal Ions on 1H NMR Signals  
Paramagnetic metal ion broadening is an alternative approach, which can be employed to probe the 
location of the peptide relative to the micelles. In this work, it can be used to probe the likely formation 
of a solvent- or metal-accessible channel or pore. Addition of Mn2+ (0.2 mM) to the G185D peptide in 
SDS micelles at pH 5.5 led to the complete disappearance of the Hα-HN cross-peaks of the C-terminal 
residues (Leu19-Tyr24) (Figure 7), which suggests that these residues are likely located outside SDS 
micelles. A 3-4 periodic (Asp7, Thr11 and Asp14) broadening of the Hα-HN cross-peaks from Asp7 to 
Leu19 was also noticed (Figure 7), indicative of a solvent-accessibility. However, less broadening was 
observed for the N-terminal residues (Val2-Gly6) in the presence of paramagnetic metal ions (Figure 
7). Further increases in Mn2+ concentration produced only a trivial effect on the remaining peaks (data 
not shown). This may suggest that the N-terminus of the peptide is embedded in the SDS micelles, 
while the C-terminus may be more solvent-exposed. Similar effects were also observed when using a 
larger paramagnetic cation of Gd3+ (data not shown). Unexpectedly, when the pH value of the solution 
was lowered in the presence of Mn2+ from 5.5 to 4.0, the intensities of the Hα-HN cross-peaks of 
majority residues (in particular Asp7, Thr11, Asp14, Phe18, Leu19 and Phe20) were almost unaffected 
by the presence of Mn2+. In addition, the C-terminal residues (e.g. Leu21, Asp22, Lys23 and Tyr24) 
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also reappeared and gained nearly 40% of their intensities compared to those in the absence of Mn2+ 
(Figure 7). This implicates that the C-terminus is also inserted into the SDS micelles at a low pH. 
 
Association of the peptide in TFE  
Diffusion measurements have been widely used to monitor self-association phenomena in proteins 
and peptides.34,50 In order to investigate the possible self-association of the peptide, the diffusion 
coefficient was measured by diffusion ordered spectroscopy (DOSY). The DOSY spectrum shows 
almost a single diffusion coefficient at 25°C with the diffusion coefficient (D) of 1.029×10-10 m2 s-1 
(Figure S2). If a prolate ellipsoid model was assumed for the peptide in TFE,34 the molecular mass for 
the G185D peptide is 8.4 kDa, corresponding to the molecular mass of a trimer of the peptide 
(molecular mass of the peptide 2.82 kDa).  
 
DISCUSSION 
DMT1 plays an important role in maintaining intracellular iron homeostasis. However, the mechanism 
through which iron was transported remains to be elucidated. The fourth transmembrane domain has 
been demonstrated to be crucial for the biological function of its integral protein.2,5 Characterization of 
the three-dimensional structure of DMT1 would be a great help in understanding its function. 
Unfortunately, it is difficult to determine the structure for large membrane proteins in the short term 
using either X-ray crystallography or NMR spectroscopy. The model peptides, corresponding to the 
sequences of potential functional segments or domain of integral proteins, were therefore used as an 
alternative approach to reveal the structure and topology of their relative integral proteins, with the 
ultimate goal of establishing the 3D structure of integral proteins.12,13,16,51 Indeed, 3D structural models 
of lactose permease with 12-transmembrane domains have been derived without using crystals 
recently, based on its transmembrane topology, secondary structure, and numerous interhelical 
contacts.52  
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    The two glycine residues located within the putative transmembrane domain 4 of Nramp proteins 
appeared to be important for the function of its integral protein, since both disease-causing mutations 
in Nramp family proteins occurred at these two glycine residues.2,9 Large proportions of glycine 
residues are often noticed in the putative TM domains of integral membrane proteins. It appears that 
glycine located within multi-spanning membrane proteins does not impart characteristics of flexibility 
normally associated with this residue, but instead plays an important role in providing a small side-
chain for packing interaction. 53 , 54  We have previously characterized the structures of a peptide, 
corresponding to the wild-type of the fourth transmembrane domain of DMT1, in membrane-like 
environments by using molecular dynamic and simulated annealing approach.19,20 In the present study, 
we aimed to investigate the effect of a substitution of the Gly185 (Gly7 in the peptide) by a negatively 
charged residue Asp on the structures, orientation and aggregation behavior of the peptide in SDS 
micelles. 
   The spatial structures of the G185D peptide in SDS micelles at various pH values have been 
determined by molecular dynamics calculations.  The peptide assumes α-helical conformations with no 
kink from Leu9 to Leu19 at pH 5.5 and is well-defined by NMR data, evidenced by the small target 
functions and RMSD values (Table I). The N-terminus (Arg1 to Gly6) is poorly defined and appeared 
to be in a random structure at all pH values. The folding of the C-terminus is highly pH-dependent. It 
is less structured and bent towards the axis of the helical core at higher pH values (5.5 and 7.4), 
whereas it becomes well-folded at a lower pH value (4.0) and the helix extends to Asp22. The 
structural characteristics of the G185D peptide are extremely similar to the wild-type peptide, although 
the helical length and spanning region are slightly different for each peptide. Glycine is well-known as 
an intrinsically flexible residue, which is capable of adopting most of the dihedral angles available in a 
Ramachandran plot.55 However, it is frequently identified as a helix-breaker in globular proteins and 
water-soluble peptides. The substitution of the Gly7 by either a large positively charged Lys 20 or a 
small negatively charged Asp does not significantly alter the spatial structures of the fourth 
transmembrane peptides in membrane-like SDS micelles.  
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The location of the G185D peptide was investigated by paramagnetic broadening of 16-doxyl-stearic 
acid spin label and Mn2+ on peptide NMR signals. Paramagnetic spin labels are known to be efficient 
relaxation agents, which selectively broaden resonances in their vicinity (∝r-6, where r is the distance 
between the paramagnetic centre and the nuclear spin).11  As illustrated in Figure 7, the peptide is 
embedded into the interior of the SDS micelles with the C-terminus surface exposed at pH 5.5. When 
the pH value is lowered from 5.5 to 4.0, the G185D peptide is likely entirely buried inside the micelles, 
as judged from little effect of Mn2+ on NOESY cross-peaks at this pH value. Mn2+ has been previously 
demonstrated as a paramagnetic probe to explore solvent-exposed residues for membrane peptides, 
since it does not enter the membrane and should only broaden the residues situated in aqueous phase or 
at the surface of detergent micelles.11 We have shown that the G185D peptide is embedded into the 
SDS micelles interior, and simultaneously noticed that Mn2+ caused significant broadening of the 
cross-peaks of hydrophilic residues Asp7, Thr11 and Asp14. The self-association of the peptide into a 
trimer in TFE as shown by the diffusion study suggests that the peptide may assume a channel in SDS 
micelles via similar association. Rapid exchange of amide protons in both N- and C-termini also 
supported the idea of formation of a pore or channel since the N-terminus is embedded in SDS 
micelles while the C-terminus resides outside of micelles at pH 5.5. It is noteworthy that a certain 
proportion of hydrophilic and even charged residues is often incorporated into the TM domains. These 
residues are important determinants of tertiary structure in multi-spanning membrane proteins.56,57 
Moreover, they are also likely to be involved in the transport process of transport proteins 58 and in the 
formation of aqueous pores in prions and other channel proteins.58,59 Both the side-chain and the 
charge distribution of the G185D peptide exhibit amphipathic characteristics (Figure 6), which support 
the idea of formation of a channel or pore. Unfortunately, we could not identify any NOEs belonging 
to intramolecular interactions, probably due to highly symmetrical assemblies. Unlike the G185R 
peptide, which displays a lower intensity and a poor signal-to-noise ratio at higher concentrations, the 
G185D peptide displayed similar intensities and signal-to-noise ratios in both 1D and 2D NMR spectra 
as the wild-type peptide. Our diffusion study has shown that the diffusion coefficient of the G185D 
peptide is almost the same as the wild-type peptide in TFE.20 This suggests that the G185D peptide 
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may exhibit similar aggregation behavior (trimer) as the wild-type peptide in SDS micelles. The 
significant broadening effects of Mn2+ may be either due to permeation or exchange of Mn2+ bound 
water with the water and amide protons in the channel. At a low pH value (4.0), the weaker effect of 
Mn2+ on peptide NMR signals is probably due to the movement of the C-termini towards the interior of 
the micelles, thereby “blocking” the Mn2+ entrance.  In contrast to both the wild-type and G185R 
peptides, neither Gly7 nor Arg7 were situated within the pore or channel, as evidenced by the weaker 
broadening effect from Mn2+.20 However, the Asp7 of the G185D peptide also dramatically broadened 
in the presence of Mn2+ at pH 5.5 (Figure 7). The Asp7 of the G185D peptide is close to and even 
included in the helical conformation in some of the calculated structures. Therefore it is reasonable to 
assume that it also participates in the formation of the channel.  
 
CONCLUSIONS 
Both CD and NMR spectroscopies showed that the G185D peptide, corresponding to the fourth 
transmembrane domain of DMT1 with G185D mutation, exhibits predominately α-helical structures in 
membrane-mimetic environments (SDS micelles). The three dimensional structure of the peptide was 
obtained by molecular dynamics calculation, using a simulated annealing approach.  The middle 
segment of the peptide forms a well-defined helical conformation, while the N-terminus is highly 
flexible and poorly defined. Interestingly, the folding of the C-terminus is triggered by pH values, and 
it forms a helical structure only at a low pH (4.0). The peptide is embedded in the SDS micelles with 
the C-terminus surface exposed at pH 5.5 or 7.4, but shrunk into the micelles at pH 4.0. It is likely to 
self-assemble to assume a water-filled channel (probably a trimer) through which metal ions may pass. 
The mutation of the Gly7 to a negatively charged and less bulky aspartate does not significantly alter 
the structure, orientation and aggregation behavior compared with the wild-type peptide. Although 
structural characterization of model peptides may not represent the active structure of the fourth TM 
domain of DMT1 in biological membranes, it may provide insights into the adaptability of channel-
forming of integral DMT1 either by self-association or by arrangement of its multi-spanning TM 
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domains, and substitution of the Gly7 by an aspartate is unlikely to abolish its properties of channel-
forming and metal permeation. 
 
We would like to thank the University of Hong Kong (URC to H.Z.S. and Q.Y.H.), Hong Kong 
Research Grants Council (HKU 7227/02M to Q.Y.H.) and the Area of Excellence Scheme of the 
University Grants Committee (Hong Kong) for financial support. The 600-MHz NMR spectrometer 
was purchased through an equipment grant (large item of equipment) from the University of Hong 
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Table I NMR Restraints and Statistics for the Ensemble of 20 Structures Calculated for the 
G185D Peptide in SDS Micelles at Different pH Values 
 
Property pH 4.0 pH 5.5 pH 7.4 
Average target functions Å2 0.071 ± 0.025 0.23 ± 0.032 0.22 ± 0.028 
Number of nonredundant distance restraints 
    Intraresidual 
    Sequential 
    Medium range 
    Long range 
197 
92 
66 
39 
0 
246 
117 
90 
39 
0 
240 
111 
87 
40 
0 
Average sum of distance restraint violations 
Average maximum distance restraints violation 
AMBER energy (Kcal mol-1) 
R.m.s. deviation from the mean structure (Å) 
    Residues 1-24 
         Backbone heavy atoms 
         All   heavy atoms 
    Residues for helical span 
         Backbone heavy atoms 
         All   heavy atoms  
Ramachandran plot statistics  
     (at each helical span) 
    Residues in most favored region (%) 
    Residues in additionally allowed region (%) 
    Residues in generously allowed region (%) 
    Residues in disallowed region (%) 
0.50 ± 0.20 
0.14 ± 0.04 
-885.5 ± 50.6 
 
 
2.75 ± 0.87 
4.25 ± 0.92 
Leu9 – Asp22 
0.46 ± 0.16 
1.34 ± 0.26 
 
 
93.7 
6.3 
0 
0 
1.70 ± 0.20 
0.20 ± 0.03 
-887.0 ± 36.0 
 
 
3.34 ± 1.05 
4.30 ± 0.95 
Val9 – Leu19 
0.24 ± 0.09 
0.92 ± 0.17 
 
 
93.2 
6.8 
0 
0 
1.60 ± 0.20 
0.18 ± 0.02 
-872.5 ± 38.1 
 
 
3.53 ± 0.93 
4.91 ± 1.20 
Val8 – Phe18 
0.34 ± 0.12 
0.96 ± 0.21 
 
 
97.7 
2.3 
0 
0 
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Figure captions: 
FIGURE 1 CD spectra of the G185D peptide in SDS micelles at pH 4.0 (solid line) and 7.4 (broken 
line). The fraction of α-helical conformation was estimated to be ca. 50% and 41% at pH 4.0 and 7.4, 
respectively. 
 
FIGURE 2 The fingerprint region of the 600-MHz NOESY spectra of 2 mM G185D peptide in 300 
mM SDS-d25 micelles at pH 5.5, 298 K, mixing time of 200 ms. The sequential assignment is also 
indicated. 
 
FIGURE 3 Chemical shift deviations of Hα of the G185D peptide in SDS micelles at different pH 
values relative to random coil values in water. 
 
FIGURE 4 Summary of NOE connectivities for the G185D peptide in SDS micelles at pH 4.0 (top); 
5.5 (middle) and 7.4 (bottom). 
 
FIGURE 5 Panel A: Superpositions of the backbone atoms for the final 20 best-converged energy-
minimized structures of the G185D peptide in SDS micelles at pH 4.0 (red), with those at pH 5.5 
(green) and pH 7.4 (blue). The structures were aligned for the best fit of the backbone of residues 
Leu9-Leu19. Panel B: Mean structure of G185D peptide in SDS micelles at pH 4.0. The side chains 
are displayed with the hydrophilic residues colored in red for negatively charged (Asp) or neutral 
residues (Thr), and in blue for positively charged residues (Arg and Lys).  
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FIGURE 6 Surface plots of the minimized average structures of the G185D peptide in SDS micelles at 
pH 4.0 and 7.4. The hydrophobic surfaces are colored in light gray, while the polar surfaces are shown 
in red (negative) and blue (positive).  
 
FIGURE 7 Residual relative intensities of Hα-HN NOESY cross-peaks of the G185D peptide in SDS 
micelles in the presence of 16-doxyl-stearic acid (5 mM) at pH 5.5 (▲); Mn2+ (0.2 mM) at pH 5.5 (?) 
and Mn2+ (0.2 mM) at pH 4.0 (?).  
 
 24
FIGURE 1 
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FIGURE 2 
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FIGURE 3 
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FIGURE 4 
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FIGURE 5 
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FIGURE 6 
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FIGURE 7 
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“NMR Structures and Orientation of the Fourth Transmembrane Domain of the Rat Divalent 
Metal Transporter (DMT1) with G185D Mutation in SDS Micelles” by H. Li et al 
 
 
FIGURE S1 Differences between Hα and HN chemical shifts of the G185D peptide and the wild-type 
DMT1-TM4 at pH 4.0 (upper panel) and 7.4 (lower panel).  
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FIGURE S2 DOSY spectrum of the G185D peptides acquired for diffusion time (∆) of 250 ms in TFE. 
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